Aspen sees risk and reward in Covid-19

08 March 2020 - 00:11 By PENELOPE MASHEGO

Aspen Pharmacare's fortunes may finally be turning around but the coronavirus could have an impact on its business as people
delay elective surgeries for fear of contracting the virus in hospital.

CEO Stephen Saad told shareholders at Aspen's interim results presentation that though the company does not have manufacturing operations in China, the virus outbreak would have consequences for it...

This article is reserved for Sunday Times subscribers.

A subscription gives you full digital access to all Sunday Times content.

Already subscribed? Simply sign in below.

Registered on the BusinessLIVE, Business Day, Financial Mail or Rand Daily Mail websites? Sign in with the same details.

Questions or problems? Email or call 0860 52 52 00.